Posted on 5월 15, 20195/15/19
How Could Policy Changes to Protected Classes Impact Part D Access and Contracting?
Posted on 4월 25, 20194/25/19
New start versus switch patients for biosimilars?
Posted on 4월 25, 20194/25/19
Care pathways—do you know where your biosimilars are used?
Posted on 4월 25, 20194/25/19
Is your biosimilar product on the payer radar?
Posted on 4월 9, 20194/9/19